A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)
PHASE3CompletedINTERVENTIONAL
Enrollment
608
Participants
Timeline
Start Date
August 20, 2013
Primary Completion Date
January 26, 2014
Study Completion Date
January 26, 2014
Conditions
Perennial Allergic Rhinitis
Interventions
DRUG
Desloratadine 5 mg
Desloratadine 5 mg tablets
DRUG
Placebo
Matching placebo to desloratadine 5 mg tablets
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT01918033 - A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200) | Biotech Hunter | Biotech Hunter